Last reviewed · How we verify
NCT04640337
Influence of Placebo on Intratissue Percutaneous Electrolysis in Patellar Tendinopathy
NA trial testing IPE applied, participants believe they are receiving IPE in Patellar Tendinopathy in 60 participants. Status unknown.
20 December 2023
Quick facts
| Lead sponsor | University of Valencia |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 16 October 2020 |
| Primary completion | 20 December 2023 |
| Estimated completion | 20 March 2024 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- IPE applied, participants believe they are receiving IPE
- IPE applied, participants believe they are receiving placebo
- IPE not applied, participants believe they are receiving IPE
- IPE not applied, participants believe they are receiving placebo
Conditions studied
- Patellar Tendinopathy — all drugs for Patellar Tendinopathy →
Sponsor
University of Valencia
Who can join
18 and older, any sex, with Patellar Tendinopathy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The main aim of this study is to verify the influence of placebo on the effectiveness of Intratissue Percutaneous Electrolysis (IPE) in patients suffering from with chronic patellar tendinopathy (PT). The secondary aim is to investigate the possible influence of the IPE on pain perception and conditioned pain modulation (CPM) in patients with chronic PT.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04640337
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Patellar Tendinopathy
Currently open trials in the same condition.
- NCT06705881 — Efficacy of the Extracorporeal Shock Wave Therapy in Athletes With Patellar Tendinopathy · NA · recruiting
- NCT06729437 — Transcranial Direct Current Stimulation on Functionality and Pain in Individuals with Patellar Tendinopathy · NA · recruiting
- NCT05407194 — Effect of Collagen/Vitamin C in Jumper's Knee; a RCT · NA · recruiting
- NCT05731037 — Influence of Restitution Time in Treatment of Patellar Tendinopathy · NA · active not recruiting
Other University of Valencia trials
Trials by the same sponsor.
- NCT07509281 — Peri-implant Tissues Changes for Different Abutment Shapes and Heights · NA · not yet recruiting
- NCT07535528 — Implant Placement Depth and Peri-Implant Tissue Outcomes · NA · not yet recruiting
- NCT07471555 — Vascular Access and Intraosseus · NA · enrolling by invitation
- NCT07463066 — Long-Term Effectiveness of Pain Neuroscience Education in Women With Genito-Pelvic Pain/Penetration Disorder. · not yet recruiting
- NCT07419399 — Acute Effects of Radiofrequency Diathermy in Postpartum Women With Diastasis Abdominis · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04640337 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Valencia
- Last refreshed: 9 May 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04640337.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing